HRT for perimenopause: evaluation and options
Perimenopause is a transition, not a single lab result. The right conversation connects symptoms, cycle history, health risks, treatment goals, and personal preferences.
At a glance
Hormone therapy can be considered during perimenopause when symptoms such as hot flashes, night sweats, sleep disruption, or vaginal and urinary changes meaningfully affect quality of life. Evaluation is usually based on age, symptoms, menstrual history, medical history, and individual risks. A hormone test is not always required, and no single formulation is right for everyone.
In this guide6 sections
Perimenopause can begin before periods stop
Perimenopause is the transition leading to menopause.1 Hormone levels fluctuate, menstrual cycles may become less predictable, and symptoms can appear while periods are still occurring. The pattern often matters more than one isolated hormone result.
Hot flashes and night sweats are common reasons to seek care. Sleep disruption, vaginal dryness, discomfort with sex, and urinary symptoms may also be related. Mood, concentration, energy, libido, and weight can change too, but those symptoms have many possible causes and deserve a broader review.
- Track cycle changes and bleeding patterns
- Note hot flashes, night sweats, sleep, and vaginal or urinary symptoms
- Record when symptoms began and how they affect daily life
- Bring a current medication, supplement, and health-history list
Testing is individualized
For many people in the usual age range with a characteristic symptom and menstrual pattern, perimenopause can be assessed clinically. Hormone levels can vary from day to day, so a single result may not settle the question.
Testing may be useful when the presentation is early, unusual, unclear, or overlaps with another condition. A clinician may consider pregnancy, thyroid disease, anemia, medication effects, sleep disorders, or other explanations based on the history.
Systemic and local therapy have different jobs
Systemic hormone therapy circulates through the body and is the most effective treatment for bothersome hot flashes and night sweats.2 Low-dose vaginal estrogen and other local options primarily address vaginal and urinary symptoms with much less systemic exposure.
If a patient has a uterus and uses systemic estrogen, a progestogen is generally added to protect the uterine lining.2 Route, dose, formulation, contraception needs, bleeding, and symptom priorities all affect the plan.
- Systemic options may include oral or transdermal therapy
- Local options focus on genitourinary symptoms
- A uterus changes the need for endometrial protection
- Hormone therapy is not contraception
Benefits and risks belong in one decision
The Menopause Society says the benefit-risk balance is generally favorable for appropriate patients who begin therapy before age 60 or within 10 years of menopause onset, particularly for bothersome symptoms.3 That population-level guidance does not replace an individual review.
Personal history of breast or endometrial cancer, unexplained bleeding, blood clots, stroke, cardiovascular disease, liver disease, migraine, and other factors can change the recommendation. FDA-approved products are generally preferred over compounded menopausal hormone therapy when an approved option can meet the patient’s needs.4
Common questions
Can I use HRT while I still have periods?
Possibly. Hormone therapy can be considered during perimenopause, but the regimen, bleeding pattern, contraception needs, and individual risks require clinician review.
Do I need a hormone test before starting HRT?
Not always. In many people, age, symptoms, and menstrual history guide the evaluation. Testing may help when the pattern is unclear or another condition is possible.
What symptoms does systemic hormone therapy treat best?
Systemic hormone therapy is the most effective treatment for bothersome hot flashes and night sweats. Other symptoms and goals require individualized discussion.
Is compounded bioidentical hormone therapy safer?
Compounded products are not FDA-approved, and ACOG recommends FDA-approved formulations over compounded therapy when approved options are available.4 The word bioidentical does not by itself establish superior safety.
References
- Source 1: ACOG: The menopause years (opens in a new tab)
- Source 2: ACOG: Hormone therapy for menopause (opens in a new tab)
- Source 3: The Menopause Society: Hormone therapy (opens in a new tab)
- Source 4: ACOG: Compounded bioidentical menopausal hormone therapy (opens in a new tab)
A number in the text links to the source for that statement.
This guide provides general educational information and is not medical advice, diagnosis, or treatment. Treatment decisions require an appropriately licensed clinician who understands your history and circumstances.